← Back to Search

Electronic Decision Aid for Genetic Testing in Inherited Cancer Syndromes

N/A

Waitlist Available

Led By Daniel C Chung, MD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from the start of the decision aid to the completion of the decision aid

Awards & highlights

Study Summary

This trial is testing whether an electronic decision aid can help people choose a multi-gene panel for cancer without the help of a genetic counselor. If it does, it will be asked participants' opinions on the decision aid.

Who is the study for?

This trial is for adults over 18 years old who have been diagnosed with a malignant ovarian tumor or pancreatic adenocarcinoma. It's not suitable for those unable to complete surveys, children under 18, or anyone who has already had germline genetic testing.Check my eligibility

What is being tested?

The study is examining the use of an electronic decision aid designed to help patients choose a multi-gene panel in consultation with their oncologist, potentially without needing a genetic counselor. Participants will evaluate the tool and make decisions about their genetic testing options.See study design

What are the potential side effects?

Since this trial involves completing surveys and using a decision aid rather than taking medication or undergoing medical procedures, there are no direct physical side effects associated with participating.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ this outcome will be measured immediately following completion of the decision aid

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~this outcome will be measured immediately following completion of the decision aid

This trial's timeline: 3 weeks for screening, Varies for treatment, and this outcome will be measured immediately following completion of the decision aid for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Participant satisfaction with how educational information is presented in the decision aid

Secondary outcome measures

Total time spent on decision aid

Trial Design

1Treatment groups

Experimental Treatment

Group I: Electronic Decision AidExperimental Treatment1 Intervention

Participants in this arm will complete an electronic decision aid for genetic testing.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,198,262 Total Patients Enrolled

Boston Medical CenterOTHER

382 Previous Clinical Trials

869,306 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,933,574 Total Patients Enrolled

2 Trials studying Genetic Testing

1,448 Patients Enrolled for Genetic Testing

Media Library

Survey of Decision Aid Clinical Trial Eligibility Overview. Trial Name: NCT04704193 — N/A

Genetic Testing Research Study Groups: Electronic Decision Aid

Genetic Testing Clinical Trial 2023: Survey of Decision Aid Highlights & Side Effects. Trial Name: NCT04704193 — N/A

Survey of Decision Aid 2023 Treatment Timeline for Medical Study. Trial Name: NCT04704193 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are receiving treatment through this clinical experiment?

"Affirmative. Data hosted on clinicaltrials.gov verifies that this medical study, which was first announced on November 20th 2020, is actively enlisting participants. A total of 100 patients must be enrolled from one location."

Answered by AI

Is this experiment actively seeking new participants?

"Affirmative. According to the details available on clinicaltrials.gov this research study is still looking for participants and has been since November 20th 2020, with its latest update taking place January 3rd 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes

Daniel C Chung 2020. "Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04704193.